ACM
Anfield Capital Management Portfolio holdings
AUM
$302M
This Quarter Return
+6.71%
1 Year Return
+14.39%
3 Year Return
+54.96%
5 Year Return
+95.56%
10 Year Return
–
AUM
$290M
AUM Growth
+$290M
(-9.5%)
Cap. Flow
-$43M
Cap. Flow
% of AUM
-14.84%
Top 10 Holdings %
Top 10 Hldgs %
62.46%
Holding
137
New
12
Increased
62
Reduced
18
Closed
37
Top Buys
| 1 |
Materials Select Sector SPDR Fund
XLB
|
$5.98M |
| 2 |
Anfield Dynamic Fixed Income ETF
ADFI
|
$2.83M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
$2.4M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
$2.2M |
| 5 |
Apple
AAPL
|
$1.42M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$12.5M |
| 2 |
Invesco QQQ Trust
QQQ
|
$11.2M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
$6.52M |
| 4 |
iShares Preferred and Income Securities ETF
PFF
|
$3.33M |
| 5 |
iShares MBS ETF
MBB
|
$3.16M |
Sector Composition
| 1 | Financials | 2.85% |
| 2 | Technology | 2.41% |
| 3 | Real Estate | 2.12% |
| 4 | Healthcare | 0.58% |
| 5 | Consumer Discretionary | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Danaher
DHR
$143B
| $201K | 0.07% |
688
+644
| +1,464% | +$188K |
|
77
Intuitive Surgical
ISRG
$158B
| $128K | 0.04% |
355
+319
| +886% | +$115K |
|
78
Regeneron Pharmaceuticals
REGN
$59.8B
| $114K | 0.04% |
181
+165
| +1,031% | +$104K |
|
79
BioNTech
BNTX
$24.1B
| $112K | 0.04% |
436
+398
| +1,047% | +$102K |
|
80
Vertex Pharmaceuticals
VRTX
$102B
| $97K | 0.03% |
440
+400
| +1,000% | +$88.2K |
|
|
FT
81
Franklin Universal Trust
FT
$199M
| $96K | 0.03% |
11,391
-1,174
| -9% | -$9.89K |
|
|
GUT
82
Gabelli Utility Trust
GUT
$529M
| $93K | 0.03% |
11,519
-1,230
| -10% | -$9.93K |
|
83
Agilent Technologies
A
$35.5B
| $81K | 0.03% |
507
+461
| +1,002% | +$73.7K |
|
84
BlackRock Income Trust
BKT
$285M
| $78K | 0.03% |
4,621
-477
| -9% | -$8.05K |
|
85
Labcorp
LH
$22.8B
| $54K | 0.02% |
199
+182
| +1,071% | +$49.4K |
|
86
Quest Diagnostics
DGX
$20.1B
| $37K | 0.01% |
212
+194
| +1,078% | +$33.9K |
|
87
Qiagen
QGEN
$10.1B
| $24K | 0.01% |
400
+366
| +1,076% | +$22K |
|
88
Encompass Health
EHC
$12.5B
| $12K | ﹤0.01% |
233
+214
| +1,126% | +$11K |
|
|
BPMC
89
DELISTED
Blueprint Medicines
BPMC
| $11K | ﹤0.01% |
106
+98
| +1,225% | +$10.2K |
|
90
Catalyst Pharmaceutical
CPRX
$2.42B
| $11K | ﹤0.01% |
1,593
+1,468
| +1,174% | +$10.1K |
|
91
Halozyme
HALO
$8.75B
| $11K | ﹤0.01% |
267
+246
| +1,171% | +$10.1K |
|
92
CRISPR Therapeutics
CRSP
$4.82B
| $10K | ﹤0.01% |
136
+125
| +1,136% | +$9.19K |
|
93
InMode
INMD
$917M
| $9K | ﹤0.01% |
125
+115
| +1,150% | +$8.28K |
|
94
Innoviva
INVA
$1.32B
| $9K | ﹤0.01% |
546
+505
| +1,232% | +$8.32K |
|
95
Premier
PINC
$2.11B
| $9K | ﹤0.01% |
222
+205
| +1,206% | +$8.31K |
|
96
QuidelOrtho
QDEL
$1.87B
| $9K | ﹤0.01% |
70
+65
| +1,300% | +$8.36K |
|
97
Ironwood Pharmaceuticals
IRWD
$201M
| $8K | ﹤0.01% |
684
+633
| +1,241% | +$7.4K |
|
|
SAGE
98
DELISTED
Sage Therapeutics
SAGE
| $8K | ﹤0.01% |
187
+173
| +1,236% | +$7.4K |
|
99
Organogenesis Holdings
ORGO
$629M
| $5K | ﹤0.01% |
564
+523
| +1,276% | +$4.64K |
|
100
uniQure
QURE
$954M
| $5K | ﹤0.01% |
261
+243
| +1,350% | +$4.66K |
|